PKP-009 Evaluation of a population pharmacokinetic model of infliximab in rheumatoid arthritis for prediction of individual dosage requirements

A Padullés; N Padullés; N Lloberas-Blanch; X Juanola; FJ Narvaez; E Leiva; S Cobo; J Bas; J Climent; M Carrere; H Colom

doi:10.1136/ejhpharm-2016-000875.412

Article info

Pharmacokinetics and pharmacodynamics

PKP-009 Evaluation of a population pharmacokinetic model of infliximab in rheumatoid arthritis for prediction of individual dosage requirements

Authors

A Padullés 1Hospital Universitari de Bellvitge. IDIBELL, Pharmacy, Barcelona, Spain PubMed articles Google scholar articles
N Padullés 1Hospital Universitari de Bellvitge. IDIBELL, Pharmacy, Barcelona, Spain PubMed articles Google scholar articles
N Lloberas-Blanch 2Hospital Universitari de Bellvitge. IDIBELL, Rheumatology, Barcelona, Spain PubMed articles Google scholar articles
X Juanola 2Hospital Universitari de Bellvitge. IDIBELL, Rheumatology, Barcelona, Spain PubMed articles Google scholar articles
FJ Narvaez 2Hospital Universitari de Bellvitge. IDIBELL, Rheumatology, Barcelona, Spain PubMed articles Google scholar articles
E Leiva 1Hospital Universitari de Bellvitge. IDIBELL, Pharmacy, Barcelona, Spain PubMed articles Google scholar articles
S Cobo 1Hospital Universitari de Bellvitge. IDIBELL, Pharmacy, Barcelona, Spain PubMed articles Google scholar articles
J Bas 3Hospital Universitari de Bellvitge. IDIBELL, Immunology, Barcelona, Spain PubMed articles Google scholar articles
J Climent 3Hospital Universitari de Bellvitge. IDIBELL, Immunology, Barcelona, Spain PubMed articles Google scholar articles
M Carrere 1Hospital Universitari de Bellvitge. IDIBELL, Pharmacy, Barcelona, Spain PubMed articles Google scholar articles
H Colom 4School of Pharmacy Universitat de Barcelona, Pharmacy and Pharmaceutical Technology Department, Barcelona, Spain PubMed articles Google scholar articles

Citation

Padullés A, Padullés N, Lloberas-Blanch N, et al

PKP-009 Evaluation of a population pharmacokinetic model of infliximab in rheumatoid arthritis for prediction of individual dosage requirements

European Journal of Hospital Pharmacy 2016;23:A182.

Publication history

First published February 14, 2016.

Online issue publication

May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password